WildBrain: Quarterly Update - The Next 3 Months Will Likely Be Busy

WildBrain's Licensing revenue rose 35% to $25.1M, helping drive a 38% increase in EBITDA to $5.8M despite weaker studio revenue from project timing. The business has $113M of cash, no debt, and active buybacks, while trading below 6x FY26 EBITDA. Further upside is tied to cost cuts and clearer segment performance as licensing strength continues to offset studio volatility.

Analysis

The key signal here is not just mix improvement; it is that the business is becoming more option-like. Licensing has much higher incremental margin than studio production, so each additional dollar of character/IP traction should translate disproportionately into EBITDA and free cash flow while reducing earnings volatility from production timing. That means the market may still be underappreciating how quickly consensus can move if licensing remains sticky for two more quarters.

The second-order winner is the capital allocation story. A net-cash balance sheet plus buybacks creates a self-reinforcing setup: lower share count can mechanically amplify per-share EBITDA even if top-line growth normalizes. If management continues repurchasing stock while the multiple remains compressed, the implied yield on buybacks is effectively an accretive use of capital relative to the company’s own EBITDA base.

The main risk is that investors extrapolate licensing momentum too far just as it normalizes. This is a months-not-days story: the near-term catalyst is the next couple of reporting periods confirming whether the licensing lift is a one-off character cycle or a durable reset. The hidden bear case is that studio weakness is not merely timing but a structural de-emphasis that eventually caps overall growth if the IP pipeline does not refresh.

Consensus appears to be treating this as a cheap, low-quality media name; the more interesting read is that it is a cash-rich IP monetization vehicle with near-term optionality from cost actions. If execution stays intact, the rerating could come from both multiple expansion and revised forward EBITDA, which is why the asymmetry is better than the headline growth rate suggests.

Key Decisions for Investors

• Go long WILD.TO on a 3-6 month horizon; target a rerating toward higher-single-digit EV/EBITDA if licensing remains above trend and buybacks continue. Use a tight thesis stop if the next quarter shows licensing deceleration or margin giveback.
• Add on weakness rather than chase strength; the best entry is any pullback driven by studio revenue noise, since that likely improves the risk/reward if licensing durability is intact.
• Consider a call spread on WILD.TO for the next 2 earnings cycles to capture rerating from segment clarity and capital returns while limiting downside to the premium paid.
• For relative value, pair long WILD.TO against a more cyclical media/production peer with less balance-sheet support and lower IP monetization visibility; the spread should benefit if investors reward quality of earnings over headline revenue.
• Watch for management commentary on incremental buybacks and cost cuts; if they maintain repurchases through the next quarter, add to the position because per-share accretion becomes a second catalyst alongside operating leverage.